Loading...

K+S

XTRA:SDF
Snowflake Description

Moderate growth potential second-rate dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SDF
XTRA
€3B
Market Cap
  1. Home
  2. DE
  3. Materials
Company description

K+S Aktiengesellschaft, together with its subsidiaries, produces and sells potash, magnesium, and salt products worldwide. The last earnings update was 6 days ago. More info.


Add to Portfolio Compare Print
SDF Share Price and Events
7 Day Returns
-4.9%
XTRA:SDF
-0.2%
DE Chemicals
0.3%
DE Market
1 Year Returns
-31.8%
XTRA:SDF
-21.3%
DE Chemicals
-11.6%
DE Market
SDF Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
K+S (SDF) -4.9% -10.2% 0.2% -31.8% -24.1% -36.6%
DE Chemicals -0.2% -9.7% -3.1% -21.3% 9.4% -5%
DE Market 0.3% -3.8% 2.5% -11.6% 10.1% 7.9%
1 Year Return vs Industry and Market
  • SDF underperformed the Chemicals industry which returned -21.3% over the past year.
  • SDF underperformed the Market in Germany which returned -11.6% over the past year.
Price Volatility
SDF
Industry
5yr Volatility vs Market

Value

 Is K+S undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of K+S to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for K+S.

XTRA:SDF Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 20 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.4%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for XTRA:SDF
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.871 (1 + (1- 30%) (113.42%))
1.377
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.38
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.377 * 5.96%)
8.43%

Discounted Cash Flow Calculation for XTRA:SDF using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for K+S is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

XTRA:SDF DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 8.43%)
2019 100.96 Analyst x6 93.11
2020 178.49 Analyst x6 151.80
2021 197.19 Analyst x9 154.66
2022 392.00 Analyst x1 283.54
2023 426.00 Analyst x1 284.17
2024 451.10 Est @ 5.89% 277.51
2025 470.01 Est @ 4.19% 266.65
2026 484.12 Est @ 3% 253.29
2027 494.63 Est @ 2.17% 238.66
2028 502.48 Est @ 1.59% 223.59
Present value of next 10 years cash flows €2,227.00
XTRA:SDF DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= €502.48 × (1 + 0.23%) ÷ (8.43% – 0.23%)
€6,137.19
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €6,137.19 ÷ (1 + 8.43%)10
€2,730.91
XTRA:SDF Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €2,227.00 + €2,730.91
€4,957.91
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €4,957.91 / 191.40
€25.9
XTRA:SDF Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in XTRA:SDF represents 0.98987x of DB:SDF
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.98987x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 25.90 x 0.98987
€25.64
Value per share (EUR) From above. €25.64
Current discount Discount to share price of €16.63
= -1 x (€16.63 - €25.64) / €25.64
35.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price K+S is available for.
Intrinsic value
35%
Share price is €16.63 vs Future cash flow value of €25.64
Current Discount Checks
For K+S to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • K+S's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • K+S's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for K+S's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are K+S's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
XTRA:SDF PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in EUR €0.39
DB:SDF Share Price ** DB (2019-05-21) in EUR €16.8
Germany Chemicals Industry PE Ratio Median Figure of 17 Publicly-Listed Chemicals Companies 20.76x
Germany Market PE Ratio Median Figure of 423 Publicly-Listed Companies 20.29x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of K+S.

XTRA:SDF PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= DB:SDF Share Price ÷ EPS (both in EUR)

= 16.8 ÷ 0.39

43.03x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • K+S is overvalued based on earnings compared to the DE Chemicals industry average.
  • K+S is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does K+S's expected growth come at a high price?
Raw Data
XTRA:SDF PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 43.03x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 20 Analysts
33.3%per year
Germany Chemicals Industry PEG Ratio Median Figure of 13 Publicly-Listed Chemicals Companies 1.83x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.5x

*Line of best fit is calculated by linear regression .

XTRA:SDF PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 43.03x ÷ 33.3%

1.29x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • K+S is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on K+S's assets?
Raw Data
XTRA:SDF PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in EUR €23.29
DB:SDF Share Price * DB (2019-05-21) in EUR €16.8
Germany Chemicals Industry PB Ratio Median Figure of 19 Publicly-Listed Chemicals Companies 1.57x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.79x
XTRA:SDF PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= DB:SDF Share Price ÷ Book Value per Share (both in EUR)

= 16.8 ÷ 23.29

0.72x

* Primary Listing of K+S.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • K+S is good value based on assets compared to the DE Chemicals industry average.
X
Value checks
We assess K+S's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. K+S has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is K+S expected to perform in the next 1 to 3 years based on estimates from 20 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
33.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is K+S expected to grow at an attractive rate?
  • K+S's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • K+S's earnings growth is expected to exceed the Germany market average.
  • K+S's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
XTRA:SDF Future Growth Rates Data Sources
Data Point Source Value (per year)
XTRA:SDF Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 20 Analysts 33.3%
XTRA:SDF Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 20 Analysts 3%
Germany Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 9.3%
Germany Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
XTRA:SDF Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 20 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
XTRA:SDF Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 4,788 579 2
2022-12-31 4,673 551 2
2021-12-31 4,621 748 378 15
2020-12-31 4,461 709 309 20
2019-12-31 4,319 705 225 15
XTRA:SDF Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-03-31 4,133 400 75
2018-12-31 4,039 309 42
2018-09-30 3,854 200 13
2018-06-30 3,740 215 89
2018-03-31 3,670 273 159
2017-12-31 3,627 307 185
2017-09-30 3,536 438 154
2017-06-30 3,497 471 113
2017-03-31 3,488 419 75
2016-12-31 3,457 445 174
2016-09-30 3,508 447 302
2016-06-30 3,712 605 380

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • K+S's earnings are expected to grow significantly at over 20% yearly.
  • K+S's revenue is expected to grow by 3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
XTRA:SDF Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 20 Analyst Estimates (S&P Global) See Below

All data from K+S Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

XTRA:SDF Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 1.96 2.63 1.60 12.00
2020-12-31 1.62 2.23 1.27 17.00
2019-12-31 1.16 1.27 1.02 13.00
XTRA:SDF Past Financials Data
Date (Data in EUR Millions) EPS *
2019-03-31 0.39
2018-12-31 0.22
2018-09-30 0.07
2018-06-30 0.46
2018-03-31 0.83
2017-12-31 0.96
2017-09-30 0.80
2017-06-30 0.59
2017-03-31 0.39
2016-12-31 0.91
2016-09-30 1.58
2016-06-30 1.98

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • K+S is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess K+S's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
K+S has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has K+S performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare K+S's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • K+S's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • K+S's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • K+S's 1-year earnings growth is negative, it can't be compared to the DE Chemicals industry average.
Earnings and Revenue History
K+S's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from K+S Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

XTRA:SDF Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 4,132.80 74.70 1,004.20 15.90
2018-12-31 4,039.10 42.10 1,008.30 15.90
2018-09-30 3,853.90 12.90 813.30 11.90
2018-06-30 3,740.30 88.50 772.90 12.70
2018-03-31 3,670.40 158.80 757.60 10.90
2017-12-31 3,627.00 184.60 935.90 16.60
2017-09-30 3,536.30 153.70 834.20 16.20
2017-06-30 3,497.40 113.20 857.60 15.70
2017-03-31 3,487.50 75.00 871.80 16.10
2016-12-31 3,456.60 174.10 871.40 13.70
2016-09-30 3,507.80 301.50 967.50 14.00
2016-06-30 3,711.60 379.70 988.60 14.20
2016-03-31 3,893.90 532.90 1,011.40 14.90
2015-12-31 4,175.50 495.20 1,048.10 14.70
2015-09-30 4,203.00 428.00 1,034.20 14.40
2015-06-30 4,138.50 467.10 1,019.90 13.70
2015-03-31 4,009.80 420.00 1,000.80 12.30
2014-12-31 3,821.70 380.50 989.70 12.20
2014-09-30 3,779.50 374.00 1,003.50 11.90
2014-06-30 3,770.30 355.90 1,015.70 13.00
2014-03-31 3,859.10 351.70 1,035.00 13.50
2013-12-31 3,950.40 415.10 1,033.00 13.90
2013-09-30 3,914.10 498.10 1,010.20 12.80
2013-06-30 4,013.00 540.60 998.50 12.40
2013-03-31 4,135.00 566.50 990.00 14.70
2012-12-31 3,935.30 565.30 943.10 19.40
2012-09-30 4,015.20 570.50 954.10 23.60
2012-06-30 3,952.10 544.80 937.60 23.90

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • K+S has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • K+S used its assets less efficiently than the DE Chemicals industry average last year based on Return on Assets.
  • K+S's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess K+S's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
K+S has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is K+S's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up K+S's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • K+S is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • K+S's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of K+S's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from K+S Company Filings, last reported 1 month ago.

XTRA:SDF Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 4,458.40 3,632.80 498.90
2018-12-31 4,144.10 3,447.50 252.90
2018-09-30 4,190.80 3,564.40 697.90
2018-06-30 4,138.00 3,180.90 356.70
2018-03-31 4,001.50 3,146.20 465.10
2017-12-31 4,160.70 3,194.70 252.70
2017-09-30 4,263.50 2,960.60 404.20
2017-06-30 4,295.70 2,987.10 522.30
2017-03-31 4,609.70 2,641.90 319.10
2016-12-31 4,552.20 2,585.20 246.40
2016-09-30 4,237.50 2,222.40 334.10
2016-06-30 4,367.70 2,122.60 468.70
2016-03-31 4,473.10 1,623.20 412.90
2015-12-31 4,295.60 1,548.90 252.30
2015-09-30 4,135.10 1,518.70 551.10
2015-06-30 4,313.90 1,519.90 602.90
2015-03-31 4,424.90 1,520.50 975.90
2014-12-31 3,974.50 1,554.30 961.50
2014-09-30 3,855.30 1,512.00 1,131.80
2014-06-30 3,575.20 2,244.30 2,068.60
2014-03-31 3,482.70 2,244.50 2,049.70
2013-12-31 3,396.60 2,258.40 1,867.50
2013-09-30 3,432.70 1,269.40 940.90
2013-06-30 3,418.40 1,266.40 906.90
2013-03-31 3,647.10 1,267.90 1,034.80
2012-12-31 3,393.90 1,270.30 786.80
2012-09-30 3,399.30 1,267.50 852.60
2012-06-30 3,248.40 1,271.60 1,003.80
  • K+S's level of debt (81.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (64.4% vs 81.5% today).
  • Debt is not well covered by operating cash flow (11%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 1.9x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess K+S's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. K+S has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is K+S's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.49%
Current annual income from K+S dividends. Estimated to be 3.36% next year.
If you bought €2,000 of K+S shares you are expected to receive €30 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • K+S's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.46%).
  • K+S's dividend is below the markets top 25% of dividend payers in Germany (3.86%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
XTRA:SDF Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 20 Analyst Estimates (S&P Global) See Below
Germany Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 3.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

XTRA:SDF Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.68 16.00
2020-12-31 0.58 20.00
2019-12-31 0.43 17.00
XTRA:SDF Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-03-14 0.250 1.442
2018-03-15 0.350 1.842
2017-03-16 0.300 1.383
2016-05-10 1.150 5.741
2015-03-12 0.900 3.479
2015-01-15 0.900 3.229
2014-03-12 0.250 1.066
2013-03-13 1.400 5.882
2012-03-16 1.300 3.614
2012-03-15 1.300 3.326
2011-03-10 1.000 2.243
2010-03-10 0.200 0.438

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • K+S has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but K+S only paid a dividend in the past 9 years.
Current Payout to shareholders
What portion of K+S's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.6x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (2.7x coverage).
X
Income/ dividend checks
We assess K+S's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can K+S afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. K+S has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of K+S's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Burkhard Lohr
COMPENSATION €3,019,500
AGE 55
TENURE AS CEO 2 years
CEO Bio

Dr. Burkhard Lohr has been Chairman of the Board of Executive Directors at K+S Aktiengesellschaft since May 12, 2017 and has been its Member of Board of Executive Directors since June 01, 2012. Dr. Lohr is also Personnel Director at K+S Aktiengesellschaft since 2018. Dr. Lohr had been the Chief Financial Officer at K+S Aktiengesellschaft since March 14, 2012 Dr. Lohr served as the Chief Financial Officer and Labor Relations Director of Hochtief AG. He was responsible for Accounting, Tax, Risk Management, Financial and Investor Relations and Controlling of Hochtief. He joined to the Executive Board of HOCHTIEF construction AG in January 2002. He joined Hochtief in 1993 and has held various senior accounting and commercial positions. Dr. Lohr has experience in building, civil and structural engineering units. He served as a Member of the Executive Board of Hochtief AG from January 1, 2006 to October 18, 2011. Dr. Lohr served as a Non Executive Director of Leighton Holdings Ltd. from May 29, 2008 to October 12, 2011. He served as a Director of Leighton Finance (USA) Pty Ltd. Dr. Lohr is a graduate in Business Studies from Cologne University and received his Doctorate from the Technical University of Braunschweig in 2001.

CEO Compensation
  • Burkhard's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Burkhard's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the K+S management team in years:

2
Average Tenure
55
Average Age
  • The tenure for the K+S management team is about average.
Management Team

Burkhard Lohr

TITLE
Chairman of the Board of Executive Directors
COMPENSATION
€3M
AGE
55
TENURE
2 yrs

Thorsten Boeckers

TITLE
CFO & Member of Board of Executive Directors
COMPENSATION
€2M
AGE
43
TENURE
2 yrs

Mark Roberts

TITLE
COO & Member of Board of Executive Directors
COMPENSATION
€2M
AGE
55
TENURE
6.6 yrs

Frauke Riva

TITLE
Head of Corporate Communications
TENURE
1.3 yrs

Michael Wudonig

TITLE
Head of Public Relations

Oliver Morgenthal

TITLE
Head of Public Affairs

Katja Seeger

TITLE
Head of Online & Project Communications

Hans-Jürgen Müller

TITLE
Head of Representative Office Berlin
Board of Directors Tenure

Average tenure and age of the K+S board of directors in years:

3.7
Average Tenure
59
Average Age
  • The tenure for the K+S board of directors is about average.
Board of Directors

Andreas Kreimeyer

TITLE
Chairman of Supervisory Board
COMPENSATION
€248K
AGE
63
TENURE
2 yrs

Ralf Becker

TITLE
Deputy Chairman of Supervisory Board
COMPENSATION
€160K
AGE
53
TENURE
1 yrs

Thomas Kölbl

TITLE
Shareholder Representative Supervisory Board Member
COMPENSATION
€130K
AGE
56
TENURE
2 yrs

Gerd Grimmig

TITLE
Supervisory Board Member
COMPENSATION
€69K
AGE
65
TENURE
1 yrs

Axel Hartmann

TITLE
Employee representative Supervisory Board Member
COMPENSATION
€121K
AGE
60
TENURE
6 yrs

Jella Benner-Heinacher

TITLE
Member of Supervisory Board
COMPENSATION
€129K
AGE
58
TENURE
16 yrs

George Cardona

TITLE
Member of Supervisory Board
COMPENSATION
€113K
AGE
67
TENURE
9.6 yrs

Michael Knackmuß

TITLE
Employee Representative Supervisory Board Member
COMPENSATION
€110K
AGE
43
TENURE
4.8 yrs

Philip von dem Bussche

TITLE
Supervisory Board Member
COMPENSATION
€114K
AGE
68
TENURE
4 yrs

Gerd Kübler

TITLE
Employee Representative Supervisory Board Member
COMPENSATION
€104K
AGE
51
TENURE
3.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess K+S's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. K+S has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

K+S Aktiengesellschaft, together with its subsidiaries, produces and sells potash, magnesium, and salt products worldwide. Its Potash and Magnesium Products segment produces and markets mineral fertilizers, such as potassium chloride for various crops, including cereals, corn, rice, and soy beans; fertilizer specialties for rapeseeds, potatoes, citrus fruits, vines, and vegetables; potassium and magnesium products for industrial applications; and a range of products for use in pharmaceutical, cosmetics, food processing, and animal feed industries. The company’s Salt segment manufactures and markets consumer products, such as table salt, water softening salt for home use, and dishwater salt for end users, as well as kosher and low sodium salt; and salt for food processing, industrial salt, salt for chemical use, de-icing salt, and sodium chloride brine. Its Complementary Activities segment is involved in the underground disposal of waste in potash and rock salt mines and recycling activities; the granulation of animal hygiene products, such as CATSAN and THOMAS; and trading several basic chemicals, including caustic soda, nitric acid, sodium carbonate, calcium chloride, and magnesium chloride. K+S Aktiengesellschaft offers its products primarily under the CÉRÉBOS, ESCO, K+S-LOGO, MORTON, STIER, UMBRELLA GIRL, VATEL, WINDSOR, AXAL, REGENIT, SALDORO, ACTION MELT, SEASON-ALL, SYSTEM SAVER, BIOSAL, LOBOS, KADD, KORN-KALI, PATENTKALI, and KALISEL brands. The company was founded in 1889 and is headquartered in Kassel, Germany.

Details
Name: K+S Aktiengesellschaft
SDF
Exchange: XTRA
Founded: 1889
€3,203,079,000
191,400,000
Website: http://www.k-plus-s.com
Address: K+S Aktiengesellschaft
Bertha-von-Suttner Strasse 7,
Kassel,
Hessen, 34131,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
DB SDF Bearer Shares Deutsche Boerse AG DE EUR 02. Jan 1992
OTCPK KPLU.F Bearer Shares Pink Sheets LLC US USD 02. Jan 1992
XTRA SDF Bearer Shares XETRA Trading Platform DE EUR 02. Jan 1992
LSE 0Q2N Bearer Shares London Stock Exchange GB EUR 02. Jan 1992
SWX SDF Bearer Shares SIX Swiss Exchange CH CHF 02. Jan 1992
BIT SDF Bearer Shares Borsa Italiana IT EUR 02. Jan 1992
WBAG SDF Bearer Shares Wiener Boerse AG AT EUR 02. Jan 1992
BATS-CHIXE SDFD Bearer Shares BATS 'Chi-X Europe' GB EUR 02. Jan 1992
OTCPK KPLU.Y ADR Pink Sheets LLC US USD 12. Feb 2009
XTRA SDF1 ADR XETRA Trading Platform DE EUR 12. Feb 2009
BST SDF1 ADR Boerse-Stuttgart DE EUR 12. Feb 2009
Number of employees
Current staff
Staff numbers
14,654
K+S employees.
Industry
Fertilizers and Agricultural Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/21 21:19
End of day share price update: 2019/05/21 00:00
Last estimates confirmation: 2019/05/21
Last earnings filing: 2019/05/15
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.